Cargando…
Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
Autor principal: | Hamdy, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438838/ https://www.ncbi.nlm.nih.gov/pubmed/30941242 http://dx.doi.org/10.4048/jbc.2019.22.e3 |
Ejemplares similares
-
Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
por: Nitsche, Ulrich, et al.
Publicado: (2016) -
Ten facts about monkeypox that every anesthesiologist should know
por: Das, Akshaya K., et al.
Publicado: (2023) -
Should every Patient with MDS get Iron Chelation – Probably Yes
por: Ghosh, Kanjaksha, et al.
Publicado: (2017) -
Hairfluencer social media trends every dermatologist should know in 2021
por: Paiewonsky, Briana, et al.
Publicado: (2022) -
Neoadjuvant radiotherapy in triple-negative breast cancer: “the past should not steal the present or hide the future”
por: To, Nhu Hanh, et al.
Publicado: (2022)